Daiichi Sankyo and ZymeWorks enter immuno-oncology cross-licensing deal
- Drug Discovery Tools
- Includes Royalty or Profit Split Information
- Includes Contract
- Product or Technology Swap
- R+D and Marketing-Licensing
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.